CoChat

Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma

Königsberg, Robert, Zojer, Niklas, Ackermann, Jutta, Krömer, Elisabeth, Kittler, Harald, Fritz, Elke, Kaufmann, Hannes, Nösslinger, Thomas, Riedl, Lucia, Gisslinger, Heinz, Jäger, Ulrich, Simonitsch, Ingrid, Heinz, Renate, Ludwig, Heinz, Huber, Heinz, Drach, Johannes · 2000 · Journal of Clinical Oncology
Cited by 182

The DOI matches its Crossref record.

Abstract

PURPOSE: Recent metaphase cytogenetic studies suggested that specific chromosomal abnormalities are of prognostic significance in patients with multiple myeloma (MM). Because the true incidence of chromosomal abnormalities in MM is much higher than that detected by metaphase analysis, we used interphase fluorescence in situ hybridization (FISH) to determine the prognostic value of specific chromosomal aberrations. PATIENTS AND METHODS: Bone marrow plasma cells from 89 previously untreated patients with MM were studied consecutively by FISH to detect the deletions of 13q14, 17p13, and 11q and the presence of t(11;14)(q13;q32). FISH results were analyzed in the context of clinical parameters (response to treatment and survival after conventional-dose chemotherapy), and a multivariate analysis of prognostic factors was performed. RESULTS: By FISH, the deletion of 13q14 occurred in 40 patients (44.9%), deletion of 17p13 in 22 (24.7%), and 11q abnormalities in 14 (15.7%; seven with t(11;14)). Deletions of 13q14 and 17p13 were associated with poor response to induction treatment (46.9% v 77.3% in those without deletions, P = .006 and 40.0% v 73.2%, P = .008, respectively) and short median overall survival (OS) time (24.2 v 88.1 months, P = .008 and 16.2 v 51.3 months, P = .008, respectively). Short median OS time was also observed for patients with 11q abnormalities (13.1 v 41.6 months, P = .02). According to the number of unfavorable cytogenetic features (deletion of 13q14, deletion of 17p13, and aberrations of 11q) that were present in each patient (0 v 1 v 2 or 3), patients with significantly different OS times could be discriminated from one another (102.4 v 29.6 v 13.9 months, P < .001, respectively). CONCLUSION: For patients with MM who were treated with conventional-dose chemotherapy, interphase FISH for 13q14, 17p13, and 11q provides prognostically relevant information in addition to that provided by standard prognostic factors. This observation may be considered for risk-adapted stratifications of MM patients in future clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2000.18.4.804

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 182

Metadata

Authors
Königsberg, R., Zojer, N., Ackermann, J., Krömer, E., Kittler, H., Fritz, E., Kaufmann, H., Nösslinger, T., Riedl, L., Gisslinger, H., Jäger, U., Simonitsch, I., Heinz, R., Ludwig, H., Huber, H., & Drach, J.
Venue
Journal of Clinical Oncology
Published
2000-02-14
Volume
18
Issue
4
Pages
804-804
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W1887989049
Cited by
182
References
0
FWCI
8.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma. https://app.cochat.ai/papers/10.1200/jco.2000.18.4.804
The paper
Königsberg, R., Zojer, N., Ackermann, J., Krömer, E., Kittler, H., Fritz, E., Kaufmann, H., Nösslinger, T., Riedl, L., Gisslinger, H., Jäger, U., Simonitsch, I., Heinz, R., Ludwig, H., Huber, H., & Drach, J. (2000). Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2000.18.4.804

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.